Clinical Trial Update: Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ICP-332 in Prurigo nodularis. The study is currently recruiting to evaluate efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prurigo Nodularis

Drugs mentioned

• ICP-332

Snippet

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. | Conditions: Prurigo Nodularis (PN) | Phase 2 | Status: RECRUITING